Home › Markets › Health Care › UNCY

Unicycive Therapeutics Inc. (UNCY)

UNCY trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$3.73
-7.90% on the day
Market cap
$103.9M
Micro cap
Revenue · 2023
$675K
No prior year to compare
Net income · 2023
-$30.5M
-4525.0% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2023.

Profile

FieldValue
TickerUNCY on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2021
SEC CIK0001766140
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials · 2023

LineValue
Revenue$675K
Net income-$30.5M
Operating income-$20.8M
Net margin-4525.0%
Operating margin-3077.6%
Revenue growthNo prior-year revenue to compare
CashNot in SEC XBRL data
Total assets$14.2M
P/E (computed)Net income was not positive
P/S (computed)153.9×

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
REGISTRATION STATEMENT
S-32026-06-05
Latest annual report
ANNUAL REPORT
10-K2026-03-30
Latest quarterly / interim
QUARTERLY REPORT
10-Q2026-08-12
Latest current report
CURRENT REPORT
8-K2026-09-29
Latest proxy
CURRENT REPORT
DEFA14A2026-06-22

Source: SEC EDGAR submissions feed, 306 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
INOInovio Pharmaceuticals Inc.$0.9982-9.66%$103.2M
COYACoya Therapeutics Inc.$4.47-6.96%$105.0M
TNXPTonix Pharmaceuticals Holding Corp.$6.13-7.68%$105.1M
RANIRani Therapeutics Holdings Inc.$0.7332-2.36%$102.2M
PMVPPMV Pharmaceuticals Inc.$1.35-4.25%$101.9M
CPIXCumberland Pharmaceuticals Inc.$7.17+2.43%$107.4M
FHTXFoghorn Therapeutics Inc.$1.85-5.13%$109.9M
QUCYQuantum Cyber N.V.$1.12+8.74%$97.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier